Brief: Kiniksa Pharmaceuticals Q1 EPS USD -0.25
23/04/2024 12:30
Apr 23 (Reuters) - Kiniksa Pharmaceuticals Q1 net income USD -17.704 million. * Q1 pretax profit USD -14.276 million * Q1 operating expenses USD 96.4 million * Q1 product revenue USD 78.885 million
Recent news on Kiniksa Pharmaceuticals International
See all newsKiniksa Pharmaceuticals International, PLC reports results for the quarter ended June 30 - Earnings Summary
Kiniksa Pharmaceuticals Q2 product revenue rises on ARCALYST sales
Kiniksa Pharmaceuticals International, PLC expected to post earnings of 30 cents a share - Earnings Preview
Cardiovascular drugmaker Kiniksa's Q1 net income rises
Kiniksa Q4 revenue rises on ARCALYST sales